back to homepage

Posts From barbarabauer

FDA Releases the Pilot Version of the Clinical Outcome Assessment Compendium for Public Comment

The Purpose of the COA Compendium The pilot COA Compendium (view PDF) is part of FDA’s efforts to foster patient-focused drug development.  The COA Compendium is intended to facilitate communication

Read More

Sanofi Stock Update: Mergers, Licensure Agreements To Boost Company Revenue in 2016

Given a strong drug pipeline and company financials, analysts expect Sanofi stock to do well in 2016. Sanofi ADR (NYSE:SNY) shares closed down 1.68% on December 31, 2015. The stock’s

Read More

Whitepaper: GPCR — Drug Targets

SAVE 10%! The GPCR — Drug Targets Report on G-Protein Coupled Receptors (GPCR) covers types of various GPCR Families and ligands targeting GPCR. Included are: GPCR families: Rhodopsin, Secretin, Metabotropic glutamate and much

Read More

Pfizer and Allergan Merger to Create Uncertainty for Agencies, Execs Say

When Pfizer announced plans to acquire Allergan for $160 billion, the first questions to surface had to do with the feasibility of the deal. What are the tax implications? What

Read More

AAAS offers Online Science Careers Forum

The American Association for the Advancement of Science (AAAS) provides a professional scientific forum related to employment and career development. Moderated by Dave Jensen, who has been visible in the

Read More